Celltium Inc. is a biotechnology company focused on the discovery and development of transformative therapeutics for Charcot-Marie-Tooth disease type 1A (CMT1A) and related neurodegenerative disorders. Our proprietary high-throughput screening platform has enabled the identification of novel drug candidates targeting key molecular mechanisms involved in CMT1A, specifically the restoration of myelination. Celltium is progressing these candidates through preclinical evaluation, with a commitment to addressing the significant unmet medical need in CMT1A and similar neurological diseases.
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.celltium.com
Celltium Inc Questions
Celltium Inc's website is http://www.celltium.com
Celltium Inc's LinkedIn profile is https://www.linkedin.com/company/celltium
Celltium Inc's industry is
Biotechnology Research
Celltium Inc's top competitors are
So & Company Inc.,
Hana Pharm,
Heuron,
Streami Inc.,
Btr Groupš£ Eor, Peo & Accounting In The Nordics,
3bigs Co., Ltd.,
Ami Polymer Pvt. Ltd.,
Ps & Consulting,
Acm Global Laboratories,
Orbusneich Medical Company Ltd..
Celltium Inc's categories are Biotechnology Research
Celltium Inc's founding year is 2020
